People on the Move
Nymox
Nymox Pharmaceutical Corporation, New Jersey, has appointed Andre Monette as CFO, replacing Roy Wolvin.
Monette previously worked for 17 years as VP of Finance and Administration for the North American subsidiary of Lombard Odier Group, a private Swiss bank. Prior to joining Nymox he provided corporate consulting services in financial reporting.
Nymox researches and develops therapies for the aging patients, including NX-1207, currently in Phase III trials for the treatment of benign prostatic hyperplasia (BPH).